Survival in sporadic ALS is associated with lower p62 burden in the spinal cord
- PMID: 37414530
- PMCID: PMC10440721
- DOI: 10.1093/jnen/nlad051
Survival in sporadic ALS is associated with lower p62 burden in the spinal cord
Abstract
The autophagy marker p62 appears as a consistent component of pathological aggregates in amyotrophic lateral sclerosis (ALS) and its modulation to facilitate protein degradation has been proposed as a potential therapeutic target. Importantly, recent studies have implicated diffuse phosphorylated TDP-43 inclusions that are immuno-negative for p62 in more rapid disease, highlighting the need for better understanding of p62 involvement in ALS pathogenesis. The present study set out to assess p62 pathology in the motor neurons of 31 patients with sporadic ALS that had either a short (<2 years) or longer (4-7 years) disease duration to determine its association with pTDP-43 pathology, motor neuron loss, and survival in sporadic disease. Our results identified significantly more cytoplasmic p62 aggregates in the spinal cord of patients with a shorter survival. Disease duration demonstrated a negative association with p62 burden and density of remaining motor neurons in the spinal cord, suggesting that survival in sporadic ALS is associated with the successful clearance of lower motor neurons with p62 aggregates. These findings implicate the autophagy pathway in ALS survival and provide support for further study of p62 as a potential prognostic biomarker in ALS.
Keywords: Amyotrophic lateral sclerosis; Motor neurons; p62 pathology; pTDP-43.
© The Author(s) 2023. Published by Oxford University Press on behalf of American Association of Neuropathologists, Inc.
Conflict of interest statement
The authors have no duality or conflicts of interest to declare.
Figures


Similar articles
-
Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis.J Neuropathol Exp Neurol. 2011 May;70(5):349-59. doi: 10.1097/NEN.0b013e3182160690. J Neuropathol Exp Neurol. 2011. PMID: 21487309
-
Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.Acta Neuropathol. 2010 Jul;120(1):67-74. doi: 10.1007/s00401-010-0683-0. Epub 2010 Apr 9. Acta Neuropathol. 2010. PMID: 20379728
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis.Acta Neuropathol Commun. 2023 Nov 13;11(1):180. doi: 10.1186/s40478-023-01670-2. Acta Neuropathol Commun. 2023. PMID: 37957721 Free PMC article.
-
[Sporadic juvenile amyotrophic lateral sclerosis with neuronal basophil inclusion bodies--a nosologic entity?].Wien Med Wochenschr. 1996;146(9-10):201-2. Wien Med Wochenschr. 1996. PMID: 9012212 Review. German.
-
The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.Brain Res. 2014 Oct 10;1584:28-38. doi: 10.1016/j.brainres.2013.12.011. Epub 2013 Dec 16. Brain Res. 2014. PMID: 24355598 Review.
Cited by
-
Heterogeneous nuclear ribonucleoprotein D - an understudied subfamily affected in sporadic TDP-43 proteinopathies.Brain Commun. 2024 Nov 1;6(6):fcae352. doi: 10.1093/braincomms/fcae352. eCollection 2024. Brain Commun. 2024. PMID: 39670112 Free PMC article.
-
Small HSPs at the crossroad between protein aggregation, autophagy and unconventional secretion: clinical implications and potential therapeutic opportunities in the context of neurodegenerative diseases.Front Cell Dev Biol. 2025 May 2;13:1538377. doi: 10.3389/fcell.2025.1538377. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40385290 Free PMC article. Review.
-
Amyotrophic Lateral Sclerosis: Focus on Cytoplasmic Trafficking and Proteostasis.Mol Neurobiol. 2025 Aug;62(8):10091-10117. doi: 10.1007/s12035-025-04831-7. Epub 2025 Apr 3. Mol Neurobiol. 2025. PMID: 40180687 Free PMC article. Review.
-
TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition.Acta Neuropathol. 2024 Sep 21;148(1):45. doi: 10.1007/s00401-024-02780-4. Acta Neuropathol. 2024. PMID: 39305312 Free PMC article.
References
-
- Tan RH, Ke YD, Ittner LM, et al. ALS/FTLD: Experimental models and reality. Acta Neuropathol 2017;133:177–96 - PubMed
-
- Davidson JM, Chung RS, Lee A. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Neurobiol Dis 2022;166:105653. - PubMed
-
- Burrell JR, Halliday GM, Kril JJ, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet 2016;388:919–31 - PubMed
-
- Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942–55 - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous